Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -0.63 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 2.20 |
| Currency | USD |
Key Financial Metrics
31.80M
Revenue
-58.49M
Net Income
-0.63
EPS (Diluted)
25.45M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-137.6%
Net Profit Margin
-183.9%
EBITDA
-40.81M
Returns & Efficiency
Return on Assets (ROA)
-43.7%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-0.63
Financial Health
Total Assets
133.69M
Total Debt
-
Debt to Equity
-
Current Ratio
2.20
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | WALTHAM, MA |
| Fiscal Year | 2024 |
Peers
LILLY ELI & CO
LLY
954.09B
P/E: --
ELI LILLY & CO
LLY
954.09B
P/E: --
530.38B
P/E: --
ABBVIE INC.
ABBV
387.52B
P/E: --
270.21B
P/E: --
MERCK & CO. INC.
MRK
270.21B
P/E: --
270.21B
P/E: --
186.96B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-137.6%
Net Margin-183.9%
ROE-
ROA-43.7%
Leverage & Liquidity
Debt to Equity-
Current Ratio2.20
Total Debt-
Total Assets$133.69M
Stockholders' Equity$-8.10M
Income Statement (FY 2024)
Revenue$31.80M
Gross Profit-
Operating Income$-43.77M
Net Income$-58.49M
EPS (Diluted)$-0.63
Cash Flow (FY 2024)
Free Cash Flow$25.45M
Cash & Equivalents$103.76M
Revenue Growth401.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 828 WINTER STREET WALTHAM, MA 02451 |
| Phone | 617-833-1027 |
| Incorporated | DE, US |
| EIN | 851623397 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 144.11M |
| Stockholders' Equity | $-8.10M |
| Cash & Equivalents | $103.76M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-09
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-12
Local
424B5
Prospectus Supplement
Prospectus supplement filed under Rule 424(b)(5)
Filed: 2026-02-12
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-12
Local
424B5
Prospectus Supplement
Prospectus supplement filed under Rule 424(b)(5)
Filed: 2026-02-11
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-01-26
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-13
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-10-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-08
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | XILIO THERAPEUTICS, INC. |
| Ticker | XLO |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | -- |
| Headquarters | WALTHAM, MA |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | - |
| Revenue | 31.80M |
| Net Income | -58.49M |
| P/E Ratio | - |
| EPS | -0.63 |
| Net Margin | -183.9% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...